search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel to cut jobs at Kiryat Gat fab, says it must “position our business for the future”
2
Navan to file confidentially for IPO, betting on market reopening
3
Google’s $32 billion acquisition of Wiz draws antitrust attention
4
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
5
Andreessen Horowitz targets elite IDF alumni for startup accelerator
More news Buzzmore

Mori Arkin

5 stories about Mori Arkin
default image

Exalenz Bioscience Acquired for $49M

19.02.20|Golan Hazani
Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
default image

Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company

19.02.20|Golan Hazani
Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source
סטפן אושמן מנכ"ל Merck

Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel

20.02.18|Meir Orbach
The incubator program has a five year budget of 20 million euros
default image

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
default image

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1